| SDA-2026-04-13-H0000 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| h-0000001 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| SDA-2024-0097 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| H000001 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| SDA-2025-0001 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| test | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| h-0001 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| astrocyte-neuron-met | [Archived Hypothesis] | 0.30 | 0.48 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| exercise-bdnf-axis-p | [Archived Hypothesis] | 0.30 | 0.49 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| post-acute-viral-res | [Archived Hypothesis] | 0.30 | 0.47 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| wnt-beta-catenin-sig | [Archived Hypothesis] | 0.30 | 0.45 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| SDA-H00001 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| alzheimer's-disease, | [Archived Hypothesis] | 0.30 | 0.60 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| SDA-0001 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| proteasome-ubiquitin | [Archived Hypothesis] | 0.30 | 0.48 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| viral-trigger-parkin | [Archived Hypothesis] | 0.30 | 0.50 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| synaptic-vesicle-tra | [Archived Hypothesis] | 0.30 | 0.45 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| HYP-000001 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| proteinopathic-proce | [Archived Hypothesis] | 0.30 | 0.30 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| 1 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| SDA-7a3b2c1d-4e5f-6g | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| HYP-003 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| HYP-002 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| HYP-010 | [Archived Hypothesis] | 0.30 | 0.30 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| HYP-100 | [Archived Hypothesis] | 0.30 | 0.30 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| HYP-001 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| h-56634f41 | [Archived Hypothesis] | 0.30 | 0.10 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| hyp-001 | [Archived Hypothesis] | 0.30 | 0.00 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| h-001 | [Archived Hypothesis] | 0.30 | 0.10 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| SDA-a0b1c2d3-e4f5-67 | [Archived Hypothesis] | 0.30 | 0.10 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| h-var-9151baec88 | [Archived Hypothesis] | 0.30 | 0.05 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| HYP-0001 | [Archived Hypothesis] | 0.30 | 0.05 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| h-abc | [Archived Hypothesis] | 0.30 | 0.30 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| prion-vs-tau-alpha-s | [Archived Hypothesis] | 0.30 | 0.05 | | archived | 2026-04-14 | legacy-pre-pipeline-import-v1 |
| h-aging-h7-prs-aging | AD Polygenic Risk Score predicts transcriptomic aging acceleration in a dose-dep | 0.28 | 0.74 | | active | 2026-04-27 | SDA-2026-04-03-gap-aging-mouse-brain-v3-20260402 |
| h-173d8b11e8 | Tissue-specific interactome destabilization drives phenotype divergence in Mende | 0.28 | 0.68 | | proposed | 2026-04-27 | SDA-2026-04-08-gap-pubmed-20260406-062222-b5f44522 |
| h-c572ce9320 | Gamma Restoration Reduces Tau via Glymphatic Clearance | 0.28 | 0.22 | AQP4 (AQP4), CGRP (CALCA), VEGFR2 (KDR), p75NTR (NGFR), GSK3 | proposed | 2026-04-28 | SRB-2026-04-28-h-var-a4975bdd96 |
| h-70867d3708 | P2RY12 rs2046934 polymorphism modifies neurodegeneration risk by altering cerebr | 0.27 | 0.20 | P2RY12 (rs2046934) | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-041434-d7920f3b |
| h-b53bbd76 | Blood-Brain Barrier Metabolite Transporter Enhancement for Diagnostic and Therap | 0.27 | 0.20 | SLCO2A1 (OATP2A1) | proposed | 2026-04-26 | SDA-2026-04-16-frontier-metabolomics-f03b09d9 |
| h-9497c0a9 | Tau Propagation Blockade via Synaptic Ephrin-B2/ephrin-B Signaling Modulation | 0.27 | 0.20 | Tau Propagation Blockade | proposed | 2026-04-26 | SDA-2026-04-16-frontier-connectomics-84acb35a |
| h-11ba42d0 | [Archived Hypothesis] | 0.26 | 0.00 | | archived | 2026-04-17 | |
| h-SDA-2026-04-26-gap | P-tau217 Isoform Shift Indicates Mechanistic Transition Point for Cessation Elig | 0.24 | 0.33 | MAPT (PTM-modified conformers) | proposed | 2026-04-26 | SDA-2026-04-26-gap-debate-20260417-033134-20519caa |
| h-88312042 | PDE10A Inhibition to Bypass RGS6 Deficiency via cAMP Pathway Normalization | 0.22 | 0.15 | | proposed | 2026-04-18 | SDA-2026-04-17-gap-pubmed-20260410-145520-5692b02e |
| h-b2b732cd07 | RGS6 isoform switching or small-molecule RGS6 activation as disease-modifying th | 0.22 | 0.08 | RGS6 | proposed | 2026-04-26 | SDA-2026-04-26-gap-pubmed-20260410-145520-5692b02e-debate |
| h-b63c1b4f | C1q-Alectinib Complexation Facilitates Brain Penetration via Receptor-Mediated T | 0.16 | 0.50 | C1Q | proposed | 2026-04-18 | SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2 |
| h-518f3f28 | Direct C1q Binding Enables FcγR-Independent Complement Activation on Tumor Cells | 0.15 | 0.50 | C1Q | proposed | 2026-04-18 | SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2 |
| h-cf4ff89c | Human Serum Albumin-Mediated Displacement Creates False-Positive C1q Binding Sig | 0.13 | 0.50 | C1Q | proposed | 2026-04-18 | SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2 |
| h-47441cb2 | C1q Binding Reflects Broader Kinase Inhibitor Promiscuity Rather Than Specific C | 0.12 | 0.50 | C1Q | proposed | 2026-04-18 | SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2 |
| h-463544b1 | Alectinib Binds Mitochondrial C1q-like Proteins (C1QDC1) Rather Than Circulating | 0.12 | 0.50 | C1Q | proposed | 2026-04-18 | SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2 |
| h-d6ae0140 | C1q Binding Analysis Across ALK Inhibitor Chemical Series Would Resolve Specific | 0.12 | 0.50 | C1Q | proposed | 2026-04-18 | SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2 |